XML 147 R132.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings per Common Share (Schedule of Basic and Diluted Earnings per Common Share) (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Class of Stock [Line Items]      
Net income from continuing operations [1] $ 1,715 $ 3,065 $ 1,086
Net income from continuing operations attributable to common stockholders [1] 1,605 3,008 1,086
Loss from discontinued operations, net of tax (1) (5) [1] (1) [1]
Net income attributable to common stockholders [1] $ 1,604 $ 3,003 $ 1,085
Basic weighted-average common shares outstanding (in shares) [1],[2] 316,690,000 362,583,000 375,629,000
Diluted weighted-average common shares outstanding (in shares) [1],[2] 318,629,000 365,180,000 377,101,000
Basic earnings per common share      
Net income from continuing operations (in dollars per share) [1] $ 5.07 $ 8.30 $ 2.89
Loss from discontinued operations, net of tax (in dollars per share) [1] 0 (0.01) 0
Net income (in dollars per share) [1] 5.06 8.28 2.89
Diluted earnings per common share      
Net income from continuing operations (in dollars per share) [1] 5.04 8.24 2.88
Loss from discontinued operations, net of tax (in dollars per share) [1] 0 (0.01) 0
Net income (in dollars per share) [1] $ 5.03 $ 8.22 $ 2.88
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 0 0 800,000
Series B Preferred Stock      
Class of Stock [Line Items]      
Preferred stock dividends [1] $ (63) $ (36) $ 0
Series C Preferred Stock      
Class of Stock [Line Items]      
Preferred stock dividends [1] $ (47) $ (21) $ 0
[1] Figures in the table may not recalculate exactly due to rounding. Earnings per share is calculated based on unrounded numbers.
[2] Includes shares related to share-based compensation that vested but were not yet issued.(c)During the year ended December 31, 2020, there were 0.8 million in shares underlying share-based awards excluded because their inclusion would have been antidilutive. There were no antidilutive shares during the years ended December 31, 2022, and 2021.